Måns Agrup

1.2k citations
16 papers · 785 · 1 hit paper · h-index 5

Impact in

Papers in

Måns Agrup

12 papers receiving 780 citations

Måns Agrup's Hit Papers

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial 2019 · 578 citations
5780+2+4Years since publication100200300400500

Peers

Måns Agrup
Comparison fields: 5 of 47
  • Radiation 208
  • Pulmonary and Respiratory Medicine 498
  • Radiology, Nuclear Medicine and Imaging 83
  • Cancer Research 48
  • Oncology 60
Replace M. Seke with:
M. Seke Sweden
Marketa Skala Australia
Hima Bindu Musunuru Canada
Magnus Lagerlund Sweden
C Marion United States
Eric E. K. Yeoh Australia
Andrei Fodor Italy
M.D. Kolar United States
L. Chinsoo Cho United States
Juan Martin Magsanoc United States
Måns Agrup relative to M. Seke Sweden M. Seke's profile →
Citations per field
00.5×3.2×
M. Seke · 1×
Citations per year

Countries citing papers authored by Måns Agrup

Since Specialization
Citations

This map shows the geographic impact of Måns Agrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Måns Agrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Måns Agrup more than expected).

Fields of papers citing papers by Måns Agrup

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Måns Agrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Måns Agrup. The network helps show where Måns Agrup may publish in the future.

Co-authors

The 25 scholars most cited alongside Måns Agrup, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Måns Agrup Line = papers co-authored together Måns Agrup links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Hit paper breakdown →
2019578
2 202199
3 200060
4 200816
5 201814
6 20234
7 20234
8 20134
9 20173
10 20241
11 20251
12 20251
13 20250
14 20250
15 20240
16 20260

About Måns Agrup

Måns Agrup is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Radiation, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 16 papers that have together received 785 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (5 papers), Advanced Radiotherapy Techniques (4 papers), Glioma Diagnosis and Treatment (4 papers), Radiation Therapy and Dosimetry (3 papers), Neuroblastoma Research and Treatments (3 papers), Prostate Cancer Treatment and Research (2 papers), Telemedicine and Telehealth Implementation (1 paper) and Neurofibromatosis and Schwannoma Cases (1 paper). The work is most often cited by research in Radiation (208 citations), Pulmonary and Respiratory Medicine (498 citations), Radiology, Nuclear Medicine and Imaging (83 citations), Cancer Research (48 citations) and Oncology (60 citations). Måns Agrup has collaborated with scholars based in Sweden, Denmark and Norway. Frequent co-authors include Per Nilsson, David Norman, Björn Tavelin, L. Beckman, M. Seke, Claes Ginman, Camilla Thellenberg‐Karlsson, Elisabeth Kjellén, Bengt Johansson and Jon Kindblom. Their work appears in journals such as Acta Oncologica, Radiotherapy and Oncology, Clinical Oncology, The Lancet Oncology and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact